Mitochondrial NEK7 is imported via MTS peptides, binds SDHB to stabilize complex II conformation, prevent reverse electron transport and ROS, and thereby protects against spontaneous and experimentally induced liver fibrosis
0:00Welcome to Base by Base, the paper cast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. Today we are diving deep into chronic liver disease, which is, I mean, it's a massive global health challenge.
0:15We talking specifically about liver fibrosis. That's the scarring that happens when the liver gets damaged over a long time from, you know, chronic injury, alcohol, or increasingly fatty liver disease, and current treatments.
0:26They mostly just aim to slow things down. But what if we could just hit an off switch on the scarring process itself? Well, here's the surprise. The key might actually be in controlling the cell's power grid, the mitochondria, with a protein we thought was busy doing something completely different.
0:40Yeah, this protein has a well-known history. It was famous for managing cell division and for kicking off a major inflammatory response, but this deep dive, it reveals a totally new kind of heroic role for it.
0:51So could this radical shift from inflammation trigger to energy stabilizer be the actual key treating liver scarring. This is where it gets really interesting. It's a huge pivot. The protein is 9 by related Kine 7 or NEK 7 for short.
1:04And if you follow cell biology, you'd know any K7 from, well, the nucleus and the cytoplasm. Its resume was basically managing mitosis cell division, and most famously activating the NLRP 3 inflammosome.
1:17Ah, the NLRP 3 inflammosome. So that's essentially a molecular alarm system, right? Exactly. It triggers these huge waves of destructive inflammation. So if any K7 is known for setting off that fire alarm, it must have had a pretty bad reputation in the cell.
1:30That was absolutely the general understanding. It was a known driver of inflammation. But this work, it just completely reshuffles that. We're seeing any K7 take on a brand new identity, specifically inside the mitochondria.
1:42It's managing how liver cells, hepatites produce energy. The big discovery is that any K7 is acting as this crucial break against the very processes that cause all that destructive scarring. Okay, before we get into the nuts and bolts of how that's possible, Let's quickly acknowledge the researchers who brought all this to light.
1:58Today we celebrate the really comprehensive work of Zen Zen Sun, Lasan, and the whole team from the Children's Hospital of Nanjing Medical University. Their work, published online on November 28, 2025, has really advanced our understanding of mitochondrial health and, you know, potential new treatments for fibrosis.
2:16To really get the impact here, we have to set the clinical stage. Liver fight brosis isn't like a simple cut that heals. It's a slow burn. It's caused by chronic stress. And at the very heart of that stress is the health of the mitochondria.
2:29A liver cell's fate really hinges on whether it's mitochondria are working properly. So if the mitochondria are healthy, the cell is happy. But if they're damaged, you start to see cell death and then organ failure.
2:41Where exactly do things go wrong in that energy production line? It almost always comes down to the electron transport chain. The ETC, which is just a series of protein complexes, IT 3 and 4, that are embedded in the mitochondrial membrane.
2:55They work sort of like a series of dams using electron flow to generate ATP, the cell's energy. The problem with paper tackles is all about stability. The flow of electrons in the ETC has to be orderly.
3:08It has to move forward. If that flow gets disturbed for any reason, the whole process can short circuit. Electrons can actually start traveling backward. Against the current. Backward. That sounds like a total disaster.
3:19You call that reverse electron transport or RET? Exactly. RAT. And it is a disaster. Think of it like water being forced backward through a dam. When electrons move backward, especially through complex I.
3:31They don't make useful energy. Instead, they slam into oxygen molecules and create an explosion of reactive oxygen species, or ROS. Right. ROS. So instead of a steady stream of power, you get this massive toxic spike of oxivative stress.
3:44And that's what's killing the cells and causing the liver to scar up. That is the technical heart of the problem. This exact mechanism, ear E, and the ROS spike is involved in so many degenerative diseases.
3:55Now, remember, any K7 are protagonist with the confusing history. The researchers were looking for a totally new function, something completely separate from its known roles. They were basically giving any case 7 a new job description right inside the cell's powerhouse.
4:10So let's follow their trail. I mean, how did they even begin to suspect that this known inflammation trend was secretly moonlighting inside the energy machinery? It started with a big systematic approach.
4:21They used omex. They created what are called hepaticide-specific knockout mice. So they deleted any K7, but only in the liver cells. And then they just watch the genomic chaos unfold using RNA sequencing.
4:33And what happened when the liver cells lost their NK 7? The data was like a giant flashing arrow pointing straight at the mitochondria. The genes that were down regulated, the ones that sort of shut down when IndyK7 was missing, were overwhelmingly part of the oxidative phosphorylation pathway.
4:47OXPHOS. And OXPHOS is the little mitochondrial energy production process. So that must have been the 1st huge clue. It was the 1st major clue that any K7 wasn't just a nuclear protein. It was deeply affecting the cell's entire energy budget.
5:02Okay, so that's a genetic clue. But how big of a leap is it from there to saying any case 7 is physically in the mitochondria? It's a leap that needs proof. So they did colocalization staining, which is kind of like a molecular address check.
5:16They stained for any K7, and then they stained for standard mitochondrial markers, like Mitotracker and TOM 20. And the images were clear. Any key 7 was right there physically inside the mitochondria of the hepatites.
5:29That's fascinating. So if it's going into the mitochondria, there must be a system for that, a kind of molecular shipping label. There is. And they found it. They pinpointed 2 specific sequences of amino acids called mitochondrial target signal peptides.
5:42These little sequences are what guide any K7 across the cell and pull it right into the mitochondrial matrix. So once they knew it was physically there, the next question was obvious. What is it doing?
5:51What's it touching? And for that, I imagine they needed some pretty sophisticated molecular detective work. Who is the binding partner? They used a technique called coimmunoprecipitation, or co-IP, with mass spectrometry.
6:04You basically pull any K7 out of the cell and see what else is stuck to it. And the main protein that came out with it was Sussan AD, hydrogenes complex, iron sulfur subunit B, or SDHB for short. SDHB.
6:18That's a bit of a mouthful, but its function is absolutely critical, right? It is. STHB is a core part of complex 2 in that electron transport chain. So any case of the old inflammation trigger is physically binding to a crucial piece of the cell's energy assembly line.
6:32Okay, a structural link. But what does any K 7 do when it binds? Does it turn complex 2 on or off or something else? Something else entirely. about structural integrity. They use molecular docking and simulations.
6:43These are like digital models that show how proteins fit together. And these simulations confirmed a really strong direct binding between any case 7 and SDHB. And crucially, this binding stabilizes the whole 3D shape of complex 2.
6:55Stabilization. That's the key word. They even use this very technical metric, a decreased radius of gyration to prove it. What does that actually mean for us? It sounds complex, but it just means the protein complex literally tightens up.
7:08Think of complex 2 as this finely tuned engine part. A large radius of gyration means the parts are wobbly and loose. inefficient. When any case 7 binds, it's like a molecular scaffold. It locks the structure into a tighter, more solid shape.
7:25And that sturdiness is what makes sure the electrons flow efficiently and forward. So any K7 is the structural support that keeps the power plant from shaking itself apart. Okay, now let's look at the key findings.
7:37What happens when you take that support away? Exactly. We go back to this knockout mice. And without any K7, the results were just devastating. Using electron microscopy, they saw severe mitochondrial damage, the mitochondrial were swollen, they had vacuules, the internal folds called cristae were disappearing.
7:51It sounds like an engine that's completely breaking down, getting bloated and just perfect analogy. The whole energy grid was dysfunctional. The oxygen consumption rate, a measure of respiration, just plummeted. At the same time, mitochondrial ROS and the membrane potential shot up. These are the textbook signs that the system is unstable and reverse electron transport is kicking into high gear.
8:13It's a vicious cycle then, any case 7 is lost. The complex becomes unstable, and that triggers this huge toxic energy spike. You mentioned that the activity of complex 2 was actually abnormally high, when any K7 was gone, why would it be hyperactive if the system is failing?
8:30That high activity suggests it's uncoupled. The complex is unstable, so it's just spinning its wheels frantically and inefficiently, which actually promotes RET instead of making ATP. And they found the chemical proof for this too.
8:42Metabolite analysis showed that levels of suxinate and el glitamine were way up. Why are those too important? Well, succinate is the direct fuel for complex too. High levels of it are known to literally push the machinery backward and drive RET.
8:56El glutamine is also involved in pathways that promote oxidative stress, seeing both of them spiked, confirms the chemical environment was just perfect for that destructive backward flow. And all of this molecular chaos led to actual severe liver disease in the mice.
9:10Spontaneously, yes, by just 5 months old, the mice without any case 7 in their liver develops severe dysfunction and full-blown fibrosis. All their liver function markers in the blood were through the roof, and the damage to litter cells, the hepatocytes, was basically sending out alarm signals that activated another cell type, the hepatic stellet cells, and those are the cells that actually produce the scar tissue.
9:32Okay, so there's conclusive evidence that losing any K7 causes fibrosis through this mitochondrial instability. But the real test, the gold standard, is whether putting any K7 back can stop the disease.
9:42Did they pull off a rescue? They did, exactly that. When they overexpressed any K7 using gene therapy vectors to deliver extra copies, it significantly reduced liver fibrosis. And this worked in 2 different very powerful disease models.
9:56So it wasn't a fluke. They showed it could work against a chemical toxin, and against a diet that mimics human fatty liver disease. And was this protection tied back to the mitochondria? Directly. The rescue was linked to restoring the normal mitochondrial shape, getting rid of all that swelling, and dramatically cutting down the oxidative damage.
10:16Basically, boosting any K7, put the stabilizer back in, stop the short circuit and save the liver. Now, you mentioned earlier that NK7 is famous for activating the NLRP3 and flammosum. So you think maybe the inflammation is what's really driving the fibrosis here.
10:31Did they check that A crucial point, and yes, they checked it carefully. They found that any case 7's protective role in the mitochondria was completely independent of the NLRP 3 inflammosome pathway in these cells means any case 7 really has 2 distinct jobs.
10:45One is inflammatory, the other is structural. And in this context, it's the structural job inside the mitochondria that's preventing the scarring. And just to nail it down to prove RET was the real villain, they used inhibitors.
10:57Yes. They use drugs that are known to block RET, like dimephyl malonate, or even metformin, and using these drugs successfully stop the fibrosis from getting worse in the mice that lacked any case seven.
11:08It verifies the whole chain of events. An EK7 loss leads to complex 2 instability, which triggers RET, which causes an ROS spike, which drives fibrosis. If you stop RET, you stop the disease. Okay, let's zoom out and unpack this.
11:23What does this all really mean? Any K7 is acting like a structural guardrail for the energy machinery. It's a protein from outside the ETC that's controlling the stability of a core ETC component. It's a fundamental shift in how we might look at this.
11:36We often think about the ETC in terms of its chemical function, but this study shows that its physical stability is just as important. When any K7 is gone, The unstable complex 2 triggers RET, which generates so much more destructive ROS than normal forward electron flow.
11:50So the structural integrity is what dictates the direction of the flow. And connecting this to the bigger picture. The study proves a brand new mechanism, a new checkpoint for mitochondrial health. And the clinical implication for you, the listener, is huge.
12:05It suggests that for chronic liver diseases. We shouldn't just be treating symptoms like inflammation. Instead, targeting any K7, maybe with drugs that mimic its stabilizing effect, could fix the root cause of the oxidative stress that drives a whole disease.
12:19We're talking about moving beyond just managing the damage to actually stabilizing the cell's internal machinery to prevent the failure in the 1st place. It's an incredibly precise idea. So to sum up the main insight.
12:31Any K7 binds directly to the SDHB subunit of mitochondrial complex too, and it acts as a critical structural stabilizer. That's its job. And that stability is essential for efficient forward electron transport.
12:44It prevents the damaging reverse electron transport, and the huge ROS production that follows. It shows any K7 is a pivotal guardian of mitochondrial health, and a powerful shield against liver fibrosis.
12:55This has massive implications beyond just the liver. What does this mean for other diseases driven by mitochondrial dysfunction? You know, things like certain neurodegenerative disorders or heart disease, where we already know RET and oxidative stress are major players.
13:09If a structural stabilizer can protect the liver, could it also protect the brain or the heart, that's something we'll leave for you to think about. This episode was based on an open access article under the CCBY4.0 license.
13:22You can find a direct link to the paper and the license in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating. If you'd like to support our work, use the donation link in the description.
13:34Now, stay with us for an original track created especially for this episode and inspired by the article you've just heard about. Thanks for listening, and join us next time as we explore more science, base by base.
